Dergi makalesi Açık Erişim
Jost, N.; Nagy, N.; Corici, C.; Kohajda, Z.; Horvath, A.; Acsai, K.; Biliczki, P.; Levijoki, J.; Pollesello, P.; Koskelainen, T.; Otsomaa, L.; Toth, A.; Papp, J. Gy; Varro, A.; Virag, L.
{ "@context": "https://schema.org/", "@id": 14243, "@type": "ScholarlyArticle", "creator": [ { "@type": "Person", "name": "Jost, N." }, { "@type": "Person", "affiliation": "Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary", "name": "Nagy, N." }, { "@type": "Person", "affiliation": "Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary", "name": "Corici, C." }, { "@type": "Person", "affiliation": "Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary", "name": "Kohajda, Z." }, { "@type": "Person", "affiliation": "Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary", "name": "Horvath, A." }, { "@type": "Person", "affiliation": "Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary", "name": "Acsai, K." }, { "@type": "Person", "affiliation": "Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary", "name": "Biliczki, P." }, { "@type": "Person", "affiliation": "Orion Pharma, Espoo, Finland", "name": "Levijoki, J." }, { "@type": "Person", "affiliation": "Orion Pharma, Espoo, Finland", "name": "Pollesello, P." }, { "@type": "Person", "affiliation": "Orion Pharma, Espoo, Finland", "name": "Koskelainen, T." }, { "@type": "Person", "affiliation": "Orion Pharma, Espoo, Finland", "name": "Otsomaa, L." }, { "@type": "Person", "affiliation": "Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, H-6720 Szeged, Hungary", "name": "Toth, A." }, { "@type": "Person", "name": "Papp, J. Gy" }, { "@type": "Person", "name": "Varro, A." }, { "@type": "Person", "name": "Virag, L." } ], "datePublished": "2013-01-01", "description": "Background and PurposeAt present there are no small molecule inhibitors that show strong selectivity for the Na+/Ca2+ exchanger (NCX). Hence, we studied the electrophysiological effects of acute administration of ORM-10103, a new NCX inhibitor, on the NCX and L-type Ca2+ currents and on the formation of early and delayed afterdepolarizations.", "headline": "ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart", "identifier": 14243, "image": "https://aperta.ulakbim.gov.tr/static/img/logo/aperta_logo_with_icon.svg", "license": "http://www.opendefinition.org/licenses/cc-by", "name": "ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart", "url": "https://aperta.ulakbim.gov.tr/record/14243" }
Görüntülenme | 36 |
İndirme | 12 |
Veri hacmi | 4.5 kB |
Tekil görüntülenme | 33 |
Tekil indirme | 11 |